亚洲免费av电影一区二区三区,日韩爱爱视频,51精品视频一区二区三区,91视频爱爱,日韩欧美在线播放视频,中文字幕少妇AV,亚洲电影中文字幕,久久久久亚洲av成人网址,久久综合视频网站,国产在线不卡免费播放

        ?

        Prescribing Chinese patent medicines without traditional Chinese medicine training is now banned in China

        2019-09-13 06:00:00EditorGroupofTraditionalMedicineResearch
        Traditional Medicine Research 2019年5期

        Editor Group of Traditional Medicine Research

        Prescribing Chinese patent medicines without traditional Chinese medicine training is now banned in China

        Editor Group of

        Figure 1 Tong Ren Tang (600085), the market K-line

        On July 1, 2019, the website of the National Health Commission of the People’s Republic of China issued the “Notice on printing and distributing the first batch of national key monitoring and rational drugs (chemicals and biological products)” (National Health Office Medical Letter [2019] No. 558) [1], where the third article stipulates: “Other types of physicians, after not less than one year of systematically studying Chinese medicine professional knowledge and passing the examination, in accordance with the basic principles of syndrome differentiation, can issue prescriptions for Chinese patent medicine”. This mandates that Western medicine doctors in China no longer prescribe Chinese patent medicines (CPM) without completing the required training. Before the implementation of this regulation, it was common for Western medicine doctors to prescribe CPM. The market for CPM is quite large [2]. Many traditional Chinese medicine (TCM) doctors believe that Western medicine doctors who have not received specific training in TCM run the risk of incorrectly prescribing CPM [3]. In fact, the vast majority of CPM are subject to the same evaluation criteria and assessment procedures as are chemical drugs. CPM are evaluated using modern medical evaluation systems, are evaluated after they are marketed, and are subjected to standardized clinical trials rather than to evaluation using the TCM theory. Patients experiencing toxic effects from the use of TCM are found to be genetically susceptible to the effects of certain herb ingredient. For example, a recent study found that the genetic basis for susceptibility to Heshouwu (), resulting in liver damage, is the HLA-B*35:01 allele [4]. It is difficult for Western medicine doctors to identify which patients may be genetically susceptible to the toxic effects of Heshouwu (). The method of syndrome differentiation based on TCM theory has also proven to be unsuccessful in identifying this susceptibility.

        In China, Chinese and Western medicine systems are equally important, and both are held in high regard [5]. As early as the 1950s, China organized various “Western Medicine Learning TCM” classes [6] and successfully trained a group of integrated medicine physicians. At the present time, 70% of CPM are prescribed by Western medicine doctors [7]. This above-mentioned regulation restricts Western medicine doctors from prescribing CPM that patients can purchase from pharmacies, and, furthermore, compels Western medicine doctors to gain knowledge in TCM. We question whether this will result in Western medicine doctors abandoning the use of CPM. Interestingly, the stock prices of CPM companies offered in the A-share market fell after these new regulations were announced.

        :

        Editor Group of Traditional Medicine Research. Prescribing Chinese patent medicines without traditional Chinese medicine training is now banned in China. Traditional Medicine Research 2019, 4 (5): 222-223.

        1. National Health Commission of the People’s Republic of China [Internet]. Notice on printing and distributing the first batch of national key monitoring and rational drugs (chemicals and biological products). [cited 2019 July 25]. Available from: http://www.nhc.gov.cn/yzygj/s7659/201907/d356ce8a4ba1461ca66c544724dffc5e.shtml

        2. CBG [Internet]. In 2019, industry of TCM is developing rapidly and its market capacity is expanding continuously. [cited 2019 July 25]. Available from: http://free.chinabaogao.com/yiyao/201905/05541b432019.html

        3. Liu YH. Clinical compatibility of Chinese and Western medicines and analysis of irrational use of other common Chinese patent medicines. Chin Clin Ration Drug Use 2019, 12: 5-7. (Chinese)

        4. Li C, Rao T, Chen X,. HLA‐B*35:01 Allele Is a Potential Biomarker for Predicting Polygonum multiflorum–Induced Liver Injury in Humans. Hepatology, 2019, 70: 346-357.

        5. XinHua net [Internet]. White Paper-traditional Chinese medicine in China. [cited 2019 July 25]. Available from: http://www.xinhuanet.com//politics/2016-12/06/c_1120064848.htm?from=singlemessage

        6. Huang YQ. Study on the movement of Western medicine physicians learning Chinese medicine in the early period of the founding of the People's Republic of China (1955-1959). Guangzhou University of Traditional Chinese Medicine, 2006. (Chinese)

        7. National Administration of Traditional Chinese Medicine [Internet], Zhang Hongchun, member of the National Committee of the Chinese People's Political Consultative Conference: Western medicine physicians must be trained and evaluated. [cited 2019 July 25]. Available from: http://www.satcm.gov.cn/xinxifabu/gedidongtai/2019-03-05/9171.html

        10.12032/TMR20190725126

        亚洲成a人v欧美综合天堂麻豆 | 久久精品人人做人人爽| 国产第19页精品| 国产精品视频一区二区三区四 | 99久久精品免费观看国产| 亚洲无线一二三四区手机| 人人妻人人澡人人爽国产一区| 色avav色av爱avav亚洲色拍 | 精品久久久久88久久久| 高h视频在线免费观看| 日产精品一区二区在线| 亚洲精品一区二区视频| 熟女免费观看一区二区| av在线播放免费观看| 韩国三级黄色一区二区| 国产禁区一区二区三区| 成人免费播放视频777777| 无套内内射视频网站| 久久精品国产亚洲av香蕉| 国产 字幕 制服 中文 在线| 欧美两根一起进3p做受视频 | 国产裸体舞一区二区三区| 日韩欧美亚洲综合久久影院ds| 欧洲日本一线二线三线区本庄铃| 国产999精品久久久久久| 99久久国语露脸精品国产| 国产成人精品日本亚洲语音1| 久久国产综合精品欧美| 美女黄网站永久免费观看网站| 国产美女高潮流白浆视频| 天堂网日韩av在线播放一区| 日本中文字幕婷婷在线| 日韩精品熟妇一区二区三区| 亚洲色成人网站www永久| 色噜噜狠狠色综合成人网| 思思99热| 一区两区三区视频在线观看| 白白色日韩免费在线观看| 久久精品国产9久久综合| 精品无码av一区二区三区不卡| 日韩av无码一区二区三区|